Lenacapavir represents a paradigm shift in HIV prevention, offering a long-acting injectable option administered once every ...
The Access Framework outlines how, by 2030, countries can ensure that 90% of people in need of prevention services have ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...
AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...
Public health advocates on Tuesday warned a House subcommittee against a 'chaotic, rapid retreat' by the U.S. from a flagship global HIV/AIDS initiative — a program that has saved over 25 million ...
Hillary Clinton would make a major change to President Bush's AIDS program if she were in the White House, she said this week in announcing her global strategy to combat AIDS. The New York senator ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today released "Still Here," a social media video campaign designed to spark crucial ...
U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in ...
Ciara licensed the rights to her song to Gilead, returning to the studio to re-record the lyrics for their "One2PrEP" ...
As part of its effort to prevent and treat HIV, Philadelphia has launched a new online tool to connect people with a range of sexual health and community resources. "When we were doing a survey of the ...
In a landmark move to strengthen the fight against HIV/AIDS, the Federal Government has introduced Lenacapavir, a long-acting injectable drug for HIV prevention administered once every six months.
The number of Latinos with HIV or AIDS in Chicago grew nearly 17% between 2020 to 2024 while other racial groups saw a drop, ...